企業プロフィール
Artivion 株価・ニュース・カタリスト
- ティッカー:
- AORT
- 取引所:
- NYSE
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
28.32 USD (-2.81%)
終値
最終更新: 2026年8月17日
991M USD
時価総額
株価変動の要因
As of Aug 17, 2026, AORT closed down 2.81% at $28.32. No new same-company headline was identified in the current news window.
企業概要
Aortic-Disease Technologies
Artivion develops medical devices and implantable tissues for complex aortic and cardiac surgery. Its portfolio is designed around the needs of cardiac and vascular surgeons treating life-threatening aortic disease.
Surgical Products
The company supplies aortic stent grafts, surgical adhesives, mechanical heart valves and preserved cardiac and vascular tissues. These products support both open and hybrid procedures.
Endovascular Expansion
Artivion exercised its option to acquire Endospan, developer of the FDA-approved NEXUS Aortic Arch System. The transaction would expand Artivion into endovascular treatment of aortic-arch disease alongside its existing surgical portfolio.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。